We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Kidney Transplant Patients at Higher Risk of CV Events

By HospiMedica International staff writers
Posted on 23 Feb 2017
Print article
Renal transplant recipients (RTRs) are often admitted with acute myocardial infarction (AMI), according to a new study.

Researchers at St. Luke's University Health Network conducted a study to examine trends in AMI admissions for 9,243 RTRs with functioning grafts. The data were then compared to those of 160,932 patients with end-stage renal disease without transplantation (ESRD-NRT) and 5,640,851 patients without advanced kidney disease (non-ESRD/RT) admitted with AMI. Treatment strategies appeared largely unchanged during the course of the study, with the exception of an increase in primary percutaneous coronary intervention (PCI) among RTRs admitted with ST-segment elevation myocardial infarction (STEMI).

The results showed that 0.2% of AMI admissions were RTRs, with STEMI accounting for 29.3% of the total admissions. Trend analysis showed that in-hospital mortality among RTR admitted for non-STEMI decreased from 3.8% to 2.1% between 2003 and 3011, whereas the mortality rates for STEMI RTR patients remained unchanged. When compared with non-ESRD/RT, history of renal transplantation was independently associated with a decreased likelihood of STEMI at presentation. The study was published on February 15, 2017, in The American Journal of Cardiology.

“In conclusion, RTR were frequently admitted with AMI, particularly non-STEMI, and were found to have multiple coronary artery disease risk factors despite their younger age,” concluded lead author Sahil Agrawal, MD, and colleagues of the department of cardiology. “Compared with other forms of renal replacement therapy, renal transplant was associated with lower inhospital mortality.”

Cardiovascular disease is the leading cause of death in dialysis patients, and the most common cause of death and allograft loss among RTRs. ESRD is associated with an increased incidence and prevalence of a wide range of CVDs including coronary artery disease, stroke, congestive heart failure, atrial fibrillation, sudden cardiac death, pulmonary hypertension, and valvular heart disease. CVD risk factors are very common in patients with ESRD, and most patients have multiple risk factors.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vibrating Mesh Nebulizer
Aerogen Solo

Print article

Channels

Surgical Techniques

view channel
Image: The living replacement knee will be tested in clinical trials within five years (Photo courtesy of ARPA-H)

Living Knee Replacement to Revolutionize Osteoarthritis Treatment

Osteoarthritis is the most prevalent type of arthritis, characterized by the progressive deterioration of cartilage, or the protective tissue covering the bone ends, resulting in pain, stiffness, and impaired... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.